Technical briefing document on novel SARS-COV-2 variant, file attached.
SARS-CoV-2 variants if considered to have concerning epidemiological, immunological or pathogenic properties are raised for formal investigation. At this point they are designated Variant Under Investigation (VUI) with a year, month, and number. Following risk assessment with the relevant expert committee, they may be designated Variant of Concern (VOC). This variant was designated VUI 202012/01 on detection and on review re-designated as VOC 202012/01 on 18/12/2020.
For details please read the attached PDF.
We simply attempt to be fearful when others are greedy and to be greedy only when others are fearful.